1-1 of 1
Rebecca Poku, MPH
Close
Sort by
Journal Articles

Phase I/II Study of Ruxolitinib for Minimal Residual Disease in Chronic Myeloid Leukemia

Abhishek Maiti, MBBS, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Rebecca Poku, MPH, Brittany A Yearby, Stephanie Breakefield, RN, Farhad Ravandi, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3009.
https://doi.org/10.1182/blood-2018-99-113972
Published: 2018